Out Chairman Dr Marco Manca will join the Forum Risk Management  on November the 22nd 2022, invited to contribute to the session on  Applications of Artificial Intelligence in Medicine in Italy (CME accredited) hosted by the Italian Institute of Medicine . Drop by and say "hi" if you are attending!

On 20 September 2022, the consortium Board of BioDynaMo voted to transfer the technical coordination of the project to Assistant Professor  Vasileios Vavourakis at the University of Cyprus. Until now, the technical development has been coordinated from CERN, the European Laboratory for Particle Physics. untitled image by SPRKLG , licensed under CC BY 2.0 The project was launched back in 2015 as part of CERN openlab ’s work with Intel on code modernization, and received support from the CERN budget for knowledge transfer to medical applications. Its primary goal was to accelerate biological simulation. Agent-based simulation is central to a wide range of research fields, from biology to finance and social sciences. Today, BioDynaMo is a powerful software platform for creating, running and visualising all kinds of 3D agent-based simulations.   “The original simulator we used was Cortex3D, but we soon decided to join forces to design and develop a truly cutting-edge agent-based...